This topic contains a solution. Click here to go to the answer

Author Question: Steatorrhea is determined by which laboratory study? a. Gastric acid stimulation b. Urea breath ... (Read 37 times)

natalie2426

  • Hero Member
  • *****
  • Posts: 524
Steatorrhea is determined by which laboratory study?
 
  a. Gastric acid stimulation
  b. Urea breath test
  c. Culture and sensitivity
  d. Stool studies

Question 2

A patient in diabetic ketoacidosis is comatose with a temperature of 102.2  F. The nurse would suspect
 
  a. head injury.
  b. infarct of the hypothalamus.
  c. infection.
  d. heat stroke.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

huda

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

D
Steatorrhea (an increase of fat in the stool) results from malabsorption or pancreatic insufficiency and is determined with stool studies. The result of the urea breath test is positive if the patient has a Helicobacter pylori infection. Gastric acid stimulation is used for the detection of duodenal ulcers, gastric atrophy, and gastric carcinoma.

Answer to Question 2

C
A patient in diabetic ketoacidosis can experience a variety of complications, including fluid volume overload, hypoglycemia, hypokalemia or hyperkalemia, hyponatremia, cerebral edema, and infection.




natalie2426

  • Member
  • Posts: 524
Reply 2 on: Jun 25, 2018
Thanks for the timely response, appreciate it


epscape

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Gracias!

 

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library